Please assess the completion status of the following clinical trial:

Trial Title: FDM for Subacute and Chronic Extremity Pain in the ED

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: FACTORIAL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion Criteria:~1. Adults ages 18 and older with arm or leg pain for which they are presenting to the emergency department.~2. Pain has been present for greater than one week and less than three months.~3. Pain is described in terms amenable to treatment by FDM:~   * Single point of sharp pain overlying soft tissues correlating to a herniated trigger point.~  * Single point of sharp pain overlying bone correlating to a continuum distortion.~  * Line or band of pain overlying soft tissues or bone correlating to a trigger band.~4. Patient is able to speak, read, and write fluently in the English language.~5. Patient is able to be reached by telephone for follow up.~6. Patient has access to text messaging services, email, and the internet.~Exclusion Criteria:~1. Inability to make informed consent (i.e. cognitive impairment or untreated psychiatric illness that would prohibit the ability to comprehend the risks and benefits of manipulative treatment vs. standard treatment).~2. Location of pain overlies major neurovascular structures (which would thus inhibit direct manipulation in that area).~3. Chronic systemic illness or medication treatment that would make patients prone to prolonged bruising or significant swelling after manipulation, including:~   * Active chemotherapy or radiation treatment.~  * Chronic steroid use.~  * Chronic wounds due to vascular disease or diabetes.~  * End stage renal disease on dialysis (risk of calciphylaxis).~  * Immunocompromised status.~  * Lymphedema.~  * Venous stasis insufficiency.~4. Connective tissue diseases, such as Marfan's or Ehlers-Danlos.~5. Dermatologic conditions:~   * Fragile skin that would be prone to tears with manipulation.~  * Skin lesions including open wounds or rashes overlying area of pain.~6. Neurologic conditions:~   * Peripheral neuropathy limiting sensation in the area of pain.~  * Demyelinating disease involving the extremity where the pain is located.~7. Orthopedic conditions:~   * Joint replacement underlying location of pain.~  * Prior orthopedic surgery to the area of pain.~  * Fracture, known or suspected, underlying site of pain.~8. Vascular conditions:~   * Superficial venous thrombosis (SVT), thrombophlebitis, or deep venous thrombosis (DVT) or suspicion for these underlying site of pain.~  * Current treatment with anticoagulants other than aspirin.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Standard of Care, Upper Extremity Pain (Type: ACTIVE_COMPARATOR): Patients will receive standard emergency department care as determined by their treating physician for their extremity pain.
- Standard of Care, Lower Extremity Pain (Type: ACTIVE_COMPARATOR): Patients will receive standard emergency department care as determined by their treating physician for their extremity pain.
- FDM, Upper Extremity Pain (Type: EXPERIMENTAL): Patients will receive the FDM intervention for their extremity pain. They may also receive standard emergency department care as determined by their treating physician for their extremity pain.
- FDM, Lower Extremity Pain (Type: EXPERIMENTAL): Patients will receive the FDM intervention for their extremity pain. They may also receive standard emergency department care as determined by their treating physician for their extremity pain.

Based on this trial design, predict the completion outcome and termination type (if applicable).

Answer: outcome: terminate
termination_type: enrollment issues